Randomized phase II trial of S‐1 plus cisplatin or docetaxel plus cisplatin with concurrent thoracic radiotherapy for inoperable stage III non‐small cell lung cancer

Cisplatin‐based chemoradiotherapy is considered standard treatment for unresectable locally advanced non‐small‐cell lung cancer (LA‐NSCLC). This study examined two regimens of chemotherapy in concurrent chemoradiation. Eligible patients with unresectable, radically irradible LA‐NSCLC were randomized...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Med
Autori principali: Shimokawa, Tsuneo, Yamada, Kazuhiko, Tanaka, Hiroshi, Kubota, Kaoru, Takiguchi, Yuichi, Kishi, Kazuma, Saito, Haruhiro, Hosomi, Yukio, Kato, Terufumi, Harada, Daijiro, Otani, Sakiko, Kasai, Takashi, Nakamura, Yoichi, Misumi, Toshihiro, Yamanaka, Takeharu, Okamoto, Hiroaki
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2020
Soggetti:
Clinical Cancer Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7877366/
https://ncbi.nlm.nih.gov/pubmed/33319495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3641
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi